altz INDIANAPOLIS, June 15, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that patients with active psoriatic arthritis (PsA) who had inadequate response to one or two TNF inhibitors or were intolerant of TNF inhibitors treated with Taltz® (ixekizumab) achieved significant improvement in signs and symptoms of …
Tag Archives: TNF Inhibitors
June, 2017
November, 2015
-
20 November
EU Endorses Biogen and Samsung Bioepis’ Biosimilar Version of Enbrel
ZUG, Switzerland–(BUSINESS WIRE)–Biogen (NASDAQ:BIIB) today announced further progress as part of its commitment to biosimilars. Samsung Bioepis, the joint venture between Samsung Biologics and Biogen, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for the marketing authorization …
October, 2015
-
19 October
Janssen Presents Positive Results from its Phase III Study in Crohn’s Disease
HONOLULU, Oct. 19, 2015 /PRNewswire/ — Phase 3 data presented for the first time showed treatment with STELARA®(ustekinumab) induced clinical response and clinical remission in patients with moderate to severe Crohn’s disease who had previously failed conventional therapy, the majority of whom were naive to treatment with anti-tumor necrosis factor …